Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Shareholders of Mosenergo approved dividends for 2023

6/27/24 MSNG

Pyaterochka launches new franchise format

6/27/24 X5

VseInstrumenty.ru began accepting applications for participation in the IPO

6/27/24 VSEH

Bank Saint-Petersburg established a leasing company

6/26/24 BSPB

Medsi will develop the resort area

6/26/24 AFKS

Nizhny Novgorod Refinery launches AVT-6 unit

6/26/24 LKOH

VK launched a unified authorization service for businesses and developers

6/26/24 VKCO

Softline will create a platform for automation of business processes in the retail industry

6/26/24 SOFL

Rostelecom plans to buy a data center for 4,000 racks

6/26/24 RTKM

Shareholders of Sovcombank approved dividends for 2023

6/26/24 SVCB